Åbo Akademi University – high-level research in life sciences, materials and technologies for health
Åbo Akademi University’s strategy, “Åbo Akademi – breaking boundaries”, for the years 2015–2020 is the profiling of research within our strongest fields. A central aspect within two of these interrelated research profiling areas, Molecular Process and Material Technology and Drug Discovery and Diagnostics (DDD) aim to develop new advanced materials and technologies for health. Further, collaboration between DDD and the Minority profiling area will address societal and ethical issues related to patient care, utilization of medical information as well as research results. The DDD Platform is a joint research profiling area of the University of Turku and ÅAU, since drug discovery, development and diagnostics have a long history and a broad knowledge-base in Turku. ÅAU has internationally high-level expertise in research areas relevant to the DDD profiling area: pharmaceutical sciences, molecular cell biology, biochemistry, computer-aided drug discovery and drug design, chemistry, physics and material sciences. The two Universities have for decades worked closely together to develop cutting-edge infrastructure for biomedical research. Prime examples of this are the joint biocentre, BioCity Turku (www.biocity.turku.fi), and two special independent departments, the Turku Positron Emission Tomography (PET) Centre (www.turkupetcentre.fi) and the Turku Centre for Biotechnology (www.btk.fi), which provide state-of-the art infrastructures to the entire Turku research community. In addition, Turku Bioimaging (www.bioimaging.fi), the Turku Center for Disease Modeling (www.tcdm.fi), the new Auria Biobank (https://www.auriabiopankki.fi/en/) and the Turku Brain and Mind Center (www.utu.fi/en/units/tbmc/) are important parts of the local infrastructure that provide and coordinate technologies closely related to the life sciences.
For more information please visit